Thursday, 17 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14409
Articles
Company
Drug
Biosyngen’s First-in-Class Drug Candidate BRG01 Accepted for IND Review
February 4, 2025
Company
Zai Lab Reports Strong Revenue Growth in 2022 Interim Results
February 4, 2025
Company
Drug
Alphamab Oncology’s KN019 Achieves Primary Endpoint in Phase II RA Study
February 4, 2025
Company
Deals
WuXi Biologics Partners with neoX Biotech to Advance AI-Driven Drug Development
February 4, 2025
Company
Deals
Luye Pharma’s Shandong Boan Partners with Shanghai Pharmaceutical for Biologics Manufacturing
February 4, 2025
Company
Drug
Staidson’s STSP-0601 Receives Clinical Trial Approval for Hemophilia Treatment
February 4, 2025
Company
Drug
Henlius Biotech Gets FDA Nod for HLX07 Clinical Study in CSCC
February 4, 2025
Company
Deals
Suzhou Novoprotein Lists on Shanghai’s STAR Market for R&D Expansion
February 4, 2025
Company
Medical Device
Rainmed Medical’s caFFR System Receives TGA Approval for Coronary Disease Diagnosis
February 4, 2025
Company
Deals
NeuShen Therapeutics Closes $20M Series Pre-A Financing for CNS Drug Development
February 4, 2025
Company
Drug
Zelgen Files NDA for Jacktinib to Treat Myelofibrosis in China
February 4, 2025
Company
Innovent Biologics Reports 15.3% Revenue Growth in 2022 Interim Results
February 4, 2025
1
2
…
1,122
1,123
1,124
1,125
1,126
…
1,200
1,201
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?